190 related articles for article (PubMed ID: 23440732)
1. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
[TBL] [Abstract][Full Text] [Related]
3. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.
Lee KY; Ahn YM; Joo EJ; Jeong SH; Chang JS; Kim SC; Kim YS
Neurosci Lett; 2006 Mar; 395(2):175-8. PubMed ID: 16289845
[TBL] [Abstract][Full Text] [Related]
4. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
Lin YF; Huang MC; Liu HC
J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
[TBL] [Abstract][Full Text] [Related]
6. Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
Blasi G; Napolitano F; Ursini G; Di Giorgio A; Caforio G; Taurisano P; Fazio L; Gelao B; Attrotto MT; Colagiorgio L; Todarello G; Piva F; Papazacharias A; Masellis R; Mancini M; Porcelli A; Romano R; Rampino A; Quarto T; Giulietti M; Lipska BK; Kleinman JE; Popolizio T; Weinberger DR; Usiello A; Bertolino A
Am J Psychiatry; 2013 Aug; 170(8):868-76. PubMed ID: 23598903
[TBL] [Abstract][Full Text] [Related]
7. Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
Scassellati C; Rotondo A; Bonvicini C; Rossi G; Cassano GB; Gennarelli M
Psychiatr Genet; 2007 Aug; 17(4):249-50. PubMed ID: 17621172
[No Abstract] [Full Text] [Related]
8. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
9. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.
Benedetti F; Bernasconi A; Lorenzi C; Pontiggia A; Serretti A; Colombo C; Smeraldi E
Neurosci Lett; 2004 Jan; 355(1-2):37-40. PubMed ID: 14729229
[TBL] [Abstract][Full Text] [Related]
10. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.
Lavoie J; Hébert M; Beaulieu JM
Biol Psychiatry; 2014 Jul; 76(2):93-100. PubMed ID: 24138923
[TBL] [Abstract][Full Text] [Related]
12. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.
Lee YJ; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1303-8. PubMed ID: 21549170
[TBL] [Abstract][Full Text] [Related]
13. [Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].
Ivanova SA; Losenkov IS; Bokhan NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):93-100. PubMed ID: 25075421
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results.
Bersudsky Y; Shaldubina A; Kozlovsky N; Woodgett JR; Agam G; Belmaker RH
Behav Pharmacol; 2008 May; 19(3):217-24. PubMed ID: 18469539
[TBL] [Abstract][Full Text] [Related]
15. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
[TBL] [Abstract][Full Text] [Related]
16. A specific group of patients with diagnostic conversion from depression to bipolar disorder and finally to dementia as a mental GSK-3 disease: A hypothesis.
Terao T; Ishii N; Hirakawa H
Bipolar Disord; 2020 Jun; 22(4):356-359. PubMed ID: 31742842
[TBL] [Abstract][Full Text] [Related]
17. Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients.
Kozlovsky N; Belmaker RH; Agam G
Am J Psychiatry; 2000 May; 157(5):831-3. PubMed ID: 10784483
[TBL] [Abstract][Full Text] [Related]
18. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
Benedetti F; Serretti A; Colombo C; Lorenzi C; Tubazio V; Smeraldi E
Neurosci Lett; 2004 Sep; 368(2):123-6. PubMed ID: 15351432
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia.
Nadri C; Lipska BK; Kozlovsky N; Weinberger DR; Belmaker RH; Agam G
Brain Res Dev Brain Res; 2003 Mar; 141(1-2):33-7. PubMed ID: 12644246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
